1.
Schlesinger T, Kircik L, Del Rosso J, Rigel D, Lebwohl M, Berman B, Armstrong A, Bhatia N, Patel VA, Narayanan S, Koscielny V, Kasujee I. Clinician- and Patient-Reported Outcomes with Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study). J of Skin [Internet]. 2023 May 20 [cited 2024 Jul. 3];7(3):771-87. Available from: https://jofskin.org/33014/index.php/skin/article/view/2140